Revugam 50 mg Tablet 7's

Revugam 50 mg Tablet is used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. Revugam 50 mg Tablet is also used to treat severe aplastic anemia (SAA) in adults. Idiopathic thrombocytopenic purpura is an immune condition associated with low levels of platelets. Hepatitis C is an infection and inflammation of the liver caused by the hepatitis C virus. Severe aplastic anemia is a condition in which the bone marrow doesn't make enough blood cells.

Revugam 50 mg Tablet contains Eltrombopag, which belongs to the class of 'thrombopoietin receptor agonists. Thrombopoietin is a glycoprotein hormone that stimulates the formation of megakaryocytes (large bone marrow cells) and further regulates platelet production. Revugam 50 mg Tablet works by increasing these large bone marrow cells responsible for the production of platelets. Thus, Revugam 50 mg Tablet helps increase these bone marrow cells, thereby stimulating the number of platelets, which further lowers the risk of bleeding.

In some cases, Revugam 50 mg Tablet can cause common side effects like nausea, diarrhea, headache, muscle pain, tiredness, loss of appetite, fever, anemia (lack of blood cells), cough, and tingling numbness. If you notice any side effects that are not manageable, please consult your doctor.

Let your doctor know if you have any allergic reactions to Revugam 50 mg Tablet or any other medicines before starting Revugam 50 mg Tablet. Consult the doctor if you are pregnant or planning to conceive. Revugam 50 mg Tablet is not indicated for use in breastfeeding since it passes into the breast milk.

Revugam 50 mg Tablet is used to treat low platelet count and severe aplastic anemia (SAA). The detailed uses of Revugam 50 mg Tablet are as follows:

• Chronic immune thrombocytopenia (ITP): Revugam 50 mg Tablet helps prevent excessive bleeding in patients with low platelet counts.
• Severe aplastic anemia: Revugam 50 mg Tablet is used to treat severe aplastic anemia when other treatments have failed.
• Chronic hepatitis C-related thrombocytopenia: Revugam 50 mg Tablet helps maintain platelet levels before and during interferon therapy.

• Revugam 50 mg Tablet can be taken with or without food.
• Follow your doctor's instructions on the dosage and timing of this medication.
• Shake well before use. Measure the prescribed dose using a measuring cup and administer it orally.
• Avoid using regular household spoons, as they may not measure the dose correctly.

• Revugam 50 mg Tablet contains 'Eltrombopag,' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections, and severe aplastic anemia (SAA).
• Revugam 50 mg Tablet works by increasing megakaryocytes, the large bone marrow cells responsible for the production of platelets.
• The increase in these bone marrow cells stimulates the production of platelets.
• Thus, Revugam 50 mg Tablet prevents bleeding episodes by increasing the number of platelets in the blood.

• If you are known to be allergic to Revugam 50 mg Tablet or other medicines, please inform your doctor in advance.
• Brief your medical history if you have blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, liver or kidney diseases before starting Revugam 50 mg Tablet.
• Take Revugam 50 mg Tablet at least two hours before or four hours after consuming antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminium, selenium and zinc), dairy products, calcium-enriched foods and fortified juices since they interfere with the absorption of Revugam 50 mg Tablet.
• It is not recommended during pregnancy since it may have harmful effects on the foetus.
• Consult your doctor before using Revugam 50 mg Tablet if you are a breastfeeding mother.
• Do not drive or operate machinery since Revugam 50 mg Tablet may cause side effects like dizziness and tiredness, affecting your ability to concentrate and drive.
• Avoid or limit alcohol consumption with Revugam 50 mg Tablet as it may affect the efficacy of Revugam 50 mg Tablet.
• It is not recommended for children less than one year of age in ITP and children less than two years of age in SAA.